Evidence map›Paper›PMID 31409421›Full record

ArticleTrials2019

The HOSENG trial - Effect of the provision of oral self-testing for absent and refusing individuals during a door-to-door HIV-testing campaign on testing coverage: protocol of a cluster-randomized clinical trial in rural Lesotho.

Alain Amstutz, Thabo Ishmael Lejone, Lefu Khesa, Josephine Muhairwe, Bienvenu Lengo Nsakala, Katleho Tlali, Moniek Bresser, Fiona Vanobberghen, Mathebe Kopo, Mpho Kao and 4 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03598686 (Home-based Plus Self-testing to Improve HIV Testing Coverage in Rural Lesotho - a Cluster Randomized Controlled Trial in Rural Lesotho.), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03598686 nacompletednot on this map

Home-based Plus Self-testing to Improve HIV Testing Coverage in Rural Lesotho - a Cluster Randomized Controlled Trial in Rural Lesotho.

TypeinterventionalSponsorTracy GlassRan2018 to 2019Enrolled10,000ConditionsHIV, HIV/AIDSArmsOraQuick
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alain AmstutzClinical Research Unit, Department of Medicine, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051, Basel, Switzerland.
Thabo Ishmael LejoneSolidarMed, Swiss Organization for Health in Africa, Maseru West, Lesotho.
Lefu KhesaSolidarMed, Swiss Organization for Health in Africa, Maseru West, Lesotho.
Josephine MuhairweSolidarMed, Swiss Organization for Health in Africa, Maseru West, Lesotho.
Bienvenu Lengo NsakalaSolidarMed, Swiss Organization for Health in Africa, Maseru West, Lesotho.
Katleho TlaliSolidarMed, Swiss Organization for Health in Africa, Maseru West, Lesotho.
Moniek BresserClinical Research Unit, Department of Medicine, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051, Basel, Switzerland.
Fiona VanobberghenClinical Research Unit, Department of Medicine, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051, Basel, Switzerland.
Mathebe KopoSolidarMed, Swiss Organization for Health in Africa, Maseru West, Lesotho.
Mpho KaoSolidarMed, Swiss Organization for Health in Africa, Maseru West, Lesotho.
Thomas KlimkaitUniversity of Basel, 4051, Basel, Switzerland.
Manuel BattegayUniversity of Basel, 4051, Basel, Switzerland.
Niklaus Daniel LabhardtClinical Research Unit, Department of Medicine, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051, Basel, Switzerland. n.labhardt@swisstph.ch.ORCID http://orcid.org/0000-0003-3599-1791
Tracy Renée GlassClinical Research Unit, Department of Medicine, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051, Basel, Switzerland.

Funding

CIPHER grant - International AIDS Society N/ASchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 323530_177576Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung IZ07Z0_160876/1Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung PCEFP3_181355Stiftung Infektiologie beider Basel N/A
6 · The paper itself

Abstract

backgroundHIV-testing coverage remains below the targeted 90% despite efforts and resources invested. Home-based HIV-testing is a key approach endorsed by the World Health Organization (WHO), especially to reach individuals who might not seek testing otherwise. Although acceptance of testing during such campaigns is high, coverage remains low due to absent household members. This cluster-randomized trial aims to assess increase in testing coverage using oral HIV self-testing (HIVST) among individuals who are absent or decline testing during home-based HIV-testing.

methodsThe HOSENG (HOme-based SElf-testiNG) trial is a cluster-randomized, parallel-group, superiority trial in two districts of Lesotho, Southern Africa. Clusters are stratified by district, village size, and village access to the nearest health facility. Cluster eligibility criteria include: village is in catchment area of one of the study facilities, village authority provides consent, and village has a registered, capable, and consenting village health worker (VHW). In intervention clusters, HIV self-tests are provided for eligible household members who are absent or decline HIV-testing in the presence of the campaign team. In control clusters, standard of care for absent and refusing individuals applies, i.e., referral to a health facility. The primary outcome is HIV-testing coverage among individuals aged 12 years or older within 120 days after enrollment. Secondary objectives include HIV-testing coverage among other age groups, and uptake of the different testing modalities. Statistical analyses will be conducted and reported in line with CONSORT guidelines. The HOSENG trial is linked to the VIBRA (Village-Based Refill of ART) trial. Together, they constitute the GET ON (GETting tOwards Ninety) research project. DISCUSSION: The HOSENG trial tests whether oral HIVST may be an add-on during door-to-door testing campaigns towards achieving optimal testing coverage. The provision of oral self-test kits, followed up by VHWs, requires little additional human resources, finances and logistics. If cost-effective, this approach should inform home-based HIV-testing policies not only in Lesotho, but in similar high-prevalence settings.

trial registrationClinicalTrials.gov, (ID: NCT03598686 ). Registered on 25 July 2018. More information is available at www.getonproject.wordpress.com .

Indexed as

House CallsPatient Acceptance of Health CareSelf CareAdolescentAdultChildCommunity Health WorkersEquivalence Trials as TopicFemaleHealth PromotionHIV InfectionsHumansLesothoMaleMass ScreeningMiddle AgedCluster-randomized controlled trialCommunity-basedCommunity health workerHIVHIV-testing coverageImplementation researchLesothoSelf-testingSouthern AfricaVillage health worker

Identifiers

PMID31409421
PMCPMC6693145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.